Celularity Inc. Form 8-K Summary
Business Context and Reporting Period
Celularity Inc. filed a Form 8-K dated July 31, 2023, with the report signed August 4, 2023. The filing concerns a change to the company’s board of directors and committees, not quarterly or annual financial results.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Change
John Sculley, a Class III director, notified the board on July 31, 2023, of his intention to resign from the board and all committees effective August 4, 2023.
The filing states that Mr. Sculley’s resignation was not due to any disagreement with Celularity regarding its operations, policies, or practices.
Guidance, Outlook, Risks, and Unusual Items
The filing provides no financial guidance, operating outlook, contingencies, or risk-factor updates. The principal disclosed item is the board and committee resignation.
Facts for Investors to Verify
- Confirm the effective date of Mr. Sculley’s resignation: August 4, 2023.
- Review any subsequent filings for changes to board committee composition or replacement-director appointments.
- Consult Celularity’s periodic reports for financial performance, liquidity, debt, and forward-looking information, which are not included in this Form 8-K.